JMEA Corporation

JMEA Current Events & Business Updates

 

JMEA Corporation's Patent Portfolio Continues to Grow


ROCKVILLE, MD, March 20, 2017 (JMEA Corporation) -- JMEA’s patent portfolio grows to thirty one (31) issued US patents and three (3) issued European patents.  Currently, JMEA has patents issued in the spine, sports medicine, joint replacement and bone fixation technology areas.  Our specific spine technologies include: Percutaneous/MIS Fusion (spinal fusion performed through very small incisions), Dynamic Stabilization (spinal stabilization device that allows for motion at the same time), Disc Annulus Repair (repair of herniated spinal discs), and Artificial Disc technology (replacement of worn-out/damaged spinal discs and preserves motion).

JMEA Patents Issued through February 2017


United States Patents




European Patents






USPTO Issues JMEA Corporation a Patent for a Detachable Front Delivery Assembly for a Tissue Repair System


ROCKVILLE, MD, February 24, 2017 (JMEA Corporation) -- On February 21, 2017, JMEA Corporation was granted a patent by the United States Patent and Trademark Office (USPTO) for its proprietary technology for a Detachable Front Delivery Assembly for a Tissue Repair System.  This patent application was originally filed on July 18, 2012 and is part of a set of patent applications filed related to JMEA’s proprietary technology to repair the rotator cuff.


With this patent, JMEA’s patent portfolio grows to thirty one (31) issued US patents and three (3) issued European patents.  Currently, JMEA has patents issued in the spine, sports medicine, joint replacement and bone fixation technology areas.  Our specific spine technologies include: Percutaneous/MIS Fusion, Dynamic Stabilization, Disc Annulus Repair, and Artificial Disc technology.


To view this patent, please go to http://www.pat2pdf.org and search on 9572615, the patent number.



USPTO Issues JMEA Corporation a Patent for a Dynamic Stabilization
Device for the Spine
 
ROCKVILLE, MD, December 22, 2011 (JMEA Corporation) -- On December 20, 2011,
JMEA Corporation was granted a patent by the United States Patent and Trademark
Office (USPTO) for its proprietary technology for a dynamic stabilization device for the
spine.

< Click the link to the right to READ THE ENTIRE ARTICLE >

Document
JMEA News Flash December 22, 2011
 
USPTO Issues JMEA Corporation a Fourth Patent for Disc Annulus Repair  
 
ROCKVILLE, MD, December 16, 2011 (JMEA Corporation) -- On December 6, 2011,
JMEA Corporation was granted a fourth patent by the United States Patent and
Trademark Office (USPTO) for its proprietary technology to minimally invasively repair
the disc annulus and to repair other tissue.

< Click the link to the right to READ THE ENTIRE ARTICLE >

Document
JMEA News Flash December 16, 2011
 
JMEA Passes FDA Inspection with Flying Colors
 
ROCKVILLE, MD, December 12, 2011 (JMEA Corporation) – JMEA Corporation was
issued a “Notice of Inspection” (FDA 482) on October 5, 2011.  The inspection was
concluded on October 12, 2011.  JMEA was found in compliance with the current
FDA Regulations.  An FDA 483 (Inspectional Observations) was not issued.  No
warnings or deficiencies were issued.  On November 7, 2011 an Establishment Inspection Report (EIR) was issued confirming the results of the inspection.

< Click the link to the right to READ THE ENTIRE ARTICLE >

Document
JMEA News Flash December 12, 2011
 
USPTO Issues JMEA Corporation a Patent for Disc Fusion and Artificial
Disc Replacement
 
ROCKVILLE, MD, April 15, 2011 (JMEA Corporation) -- On April 12, 2011, JMEA
Corporation was granted a patent by the United States Patent and Trademark Office
(USPTO) for its proprietary technology to minimally invasively perform a spinal fusion
or artificial disc replacement.

< Click the link to the right to READ THE ENTIRE ARTICLE >


Document
JMEA News Flash April 15, 2011
 
Mr. Gregory Watko Joins JMEA Corporation as Director of Sales
 
ROCKVILLE, MD, February 8, 2011 (JMEA Corporation) -- JMEA Corporation is pleased to
announce that Gregory Watko has joined JMEA Corporation as Director of Sales.  Mr. Watko has more than 25 years of experience in orthopedic sales and sales management.  He has extensive sales management experience developing hybrid channels of distribution specializing in trauma, spine and sports medicine.

< Click the link to the right to READ THE ENTIRE ARTICLE >

Document
JMEA News Flash February 08, 2011
 
USPTO Issues JMEA Corporation a Third Patent for Disc Annulus Repair System

ROCKVILLE, MD, December 15, 2009 (JMEA Corporation) — On December 15, 2009, JMEA Corporation was granted a third patent by the United States Patent and Trademark Office (USPTO) ...

< Click the link to the right to READ THE ENTIRE ARTICLE >
Document
JMEA New Flash: December 15,2009
USPTO Issues JMEA Corporation a Second Patent for Disc Annulus Repair System

ROCKVILLE, MD, November 24, 2009 (JMEA Corporation) — On October 27, 2009, JMEA Corporation was granted a patent by the United States Patent and Trademark Office (USPTO) ...


< Click the link to the right to READ THE ENTIRE ARTICLE >


Document
JMEA New Flash: November 24,2009
USPTO Issues JMEA Corporation a Patent for Disc Annulus Repair System

ROCKVILLE, MD, June 22, 2009 (JMEA Corporation) — On June 16, 2009, JMEA Corporation was issued a patent by the United States Patent and Trademark Office (USPTO) ...

< Click the link to the right to READ THE ENTIRE ARTICLE >

Document
JMEA News Flash: June 22, 2009
FDA Clears JMEA Corporation’s Cannulated Bone Screw System for Knee Reconstruction

ROCKVILLE, MD, Sept. 16, 2008 (JMEA Corporation) — JMEA Corporation received clearance from the FDA to market its cannulated bone screw system for knee reconstruction ...


< Click the link to the right to READ THE ENTIRE ARTICLE >


Document
JMEA New Flash: September 16,2008